Sarepta Therapeutics Receives Rare Pediatric Disease Designation From FDA By: TalkMarkets August 21, 2015 at 12:03 PM EDT Sarepta receives rare pediatric disease designation from FDA for Eteplirsen to tread duchenne muscular dystrophy. Read More >> Related Stocks: Sarepta Therapeutics